nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.29	1	CbGbCtD
Adefovir Dipivoxil—SLC22A8—nephron—focal segmental glomerulosclerosis	0.06	0.166	CbGeAlD
Adefovir Dipivoxil—AK2—cortex of kidney—focal segmental glomerulosclerosis	0.0384	0.106	CbGeAlD
Adefovir Dipivoxil—Nephrotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.0344	0.0984	CcSEcCtD
Adefovir Dipivoxil—AK4—nephron tubule—focal segmental glomerulosclerosis	0.0332	0.0918	CbGeAlD
Adefovir Dipivoxil—NME1—kidney—focal segmental glomerulosclerosis	0.0302	0.0837	CbGeAlD
Adefovir Dipivoxil—AK4—kidney—focal segmental glomerulosclerosis	0.0291	0.0807	CbGeAlD
Adefovir Dipivoxil—AK4—cortex of kidney—focal segmental glomerulosclerosis	0.0284	0.0786	CbGeAlD
Adefovir Dipivoxil—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.0216	0.0599	CbGeAlD
Adefovir Dipivoxil—Nephropathy toxic—Cyclosporine—focal segmental glomerulosclerosis	0.019	0.0545	CcSEcCtD
Adefovir Dipivoxil—ABCC5—nephron tubule—focal segmental glomerulosclerosis	0.0188	0.0521	CbGeAlD
Adefovir Dipivoxil—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.0188	0.0538	CcSEcCtD
Adefovir Dipivoxil—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.0188	0.0538	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.0185	0.0512	CbGeAlD
Adefovir Dipivoxil—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0178	0.0509	CcSEcCtD
Adefovir Dipivoxil—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0156	0.0446	CcSEcCtD
Adefovir Dipivoxil—ABCC4—nephron tubule—focal segmental glomerulosclerosis	0.013	0.0361	CbGeAlD
Adefovir Dipivoxil—SLC22A8—nephron tubule—focal segmental glomerulosclerosis	0.0129	0.0358	CbGeAlD
Adefovir Dipivoxil—SLC22A3—kidney—focal segmental glomerulosclerosis	0.0118	0.0327	CbGeAlD
Adefovir Dipivoxil—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0329	CcSEcCtD
Adefovir Dipivoxil—ABCC4—kidney—focal segmental glomerulosclerosis	0.0115	0.0318	CbGeAlD
Adefovir Dipivoxil—SLC22A8—kidney—focal segmental glomerulosclerosis	0.0114	0.0315	CbGeAlD
Adefovir Dipivoxil—ABCC4—cortex of kidney—focal segmental glomerulosclerosis	0.0112	0.0309	CbGeAlD
Adefovir Dipivoxil—SLC22A8—cortex of kidney—focal segmental glomerulosclerosis	0.0111	0.0307	CbGeAlD
Adefovir Dipivoxil—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0313	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0307	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00908	0.026	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00883	0.0253	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00833	0.0239	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00743	0.0213	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00672	0.0192	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0062	0.0178	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00601	0.0172	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00596	0.0171	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00583	0.0167	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00578	0.0165	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00573	0.0164	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00549	0.0157	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00545	0.0156	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00542	0.0155	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00539	0.0154	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00538	0.0154	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00478	0.0137	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00471	0.0135	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00441	0.0126	CcSEcCtD
Adefovir Dipivoxil—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.0119	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.0116	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.0116	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00404	0.0116	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00382	0.0109	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00382	0.0109	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00379	0.0108	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00372	0.0106	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00355	0.0102	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00343	0.00982	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00339	0.0097	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.00963	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00913	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.00882	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.00882	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.00801	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.0079	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00267	0.00764	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.0071	CcSEcCtD
Adefovir Dipivoxil—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.00704	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.00703	CcSEcCtD
Adefovir Dipivoxil—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00699	CcSEcCtD
Adefovir Dipivoxil—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00663	CcSEcCtD
